PureTech Health plc (PTCHF) Comparison with companies in other sectors?

PureTech Health plc has a share price of 240.25M. You can analyze PureTech Health plc (PTCHF) competitors across different market sectors through stock heatmaps.

What are PTCHF's NET and operating margins?

PureTech Health plc (PTCHF) operating margin is around -31.54, and net profit margin is approximately 12.40 as of the latest reports.

In what way does PTCHF's earnings per share (EPS) trend reflect its financial momentum?

PureTech Health plc (PTCHF) EPS is 0.21 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for PureTech Health plc is 7.86, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for PureTech Health plc?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for PureTech Health plc like P/E which is 9.62, P/B which is 1.24, and PEG which is 0.05. Compare them with sector averages to evaluate if the stock is priced fairly.

PureTech Health plc

PTCHF•PNK

Healthcare

Biotechnology

$1.77

$0.00(0.00%)

PureTech Health plc (PTCHF) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$0.21

P/E Ratio

7.86

ROE

0.15%

Net Margin

12.40%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$396.42M

Shares OutstandingTotal number of shares issued

$240.25M

Book Value/ShareNet worth per share

$1.51

Revenue/ShareAnnual revenue per share

$0.02

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.21

Net MarginNet income as percentage of revenue

1240.09%

Operating MarginOperating income as percentage of revenue

-3154.00%

ROEReturn on shareholders' equity

14.65%

ROAReturn on total assets

8.88%

ROCEReturn on capital employed

-24.25%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.50

Cash/ShareCash and equivalents per share

$1.36

FCF YieldFree cash flow as percentage of market cap

-28.82%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for PTCHFFinancial Ratios Analysis details for PTCHF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for PTCHFSector Benchmarking details for PTCHF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for PureTech Health plc Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of PureTech Health plc. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account PureTech Health plc's unique business strengths and challenges.

Key Financial Metrics for PureTech Health plc

For PureTech Health plc, essential financial indicators include EPS 0.21, PE 7.86, and ROE 0.15. These key ratios reveal insights into PureTech Health plc's profitability, valuation, and operational health. Understanding these metrics enables you to compare PureTech Health plc with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of PureTech Health plc

Metrics like Net Margin 1240.09% and ROA 8.88% shed light on how well PureTech Health plc is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether PureTech Health plc can sustain its operations and continue growing in the future.

Valuation and Market Position of PureTech Health plc

Using ratios such as P/B Ratio 1.24 and PEG Ratio 0.05, investors can assess whether PureTech Health plc is appropriately valued based on its financials and growth potential. These figures, combined with PureTech Health plc's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for PureTech Health plc

Financial health indicators, such as Debt/Equity Ratio 0.05 and Cash Flow $-0.50, provide a snapshot of PureTech Health plc's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like PureTech Health plc, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for PureTech Health plc

Investing in PureTech Health plc based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at PureTech Health plc focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;